A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension-Reference-Cited by-同舟云学术

A randomised, double-blind, double-dummy comparison of the efficacy and tolerability of lercanidipine tablets and losartan tablets in patients with mild to moderate essential hypertension

Published:2002-08 Issue:8 Volume:16 Page:605-610
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

James I G V,Jones A,Davies P

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/1001430.pdf

Reference17 articles.

1. Ramsay LE et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society J Hum Hypertens 1999; 13: 569–592

2. Circo A . Active dose findings for lercanidipine in a double-blind, placebo-controlled design inpatients with mild to moderate hypertension J Cardiovasc Pharmacol 1997; 29 (Suppl 2): S21–S25

3. Barbagallo M, Barbagallo-Sangiorgi G . Efficacy and tolerability of lercanidipine in monotherapy in elderlypatients with isolated systolic hypertension Aging (Milano) 2000; 12: 375–379

4. Herbette LG, Vecchiarelli M, Leonardi A . Lercanidipine: short plasma half-life, long duration of action. A molecular model to rationalize its pharmacokinetic properties J Cardiovasc Pharmacol 1997; 29 (Suppl 1): S19–S24

5. Morisco C, Trimarco B . Efficacy and tolerability of lercanidipine in comparison to and in combination with atenolol inpatients with mild to moderate hypertension in a double-blind controlled study J Cardiovasc Pharmacol 1997; 29 (Suppl 2): S26–S30

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13

2. Lercanidipine in the management of hypertension: An update;Journal of Pharmacology and Pharmacotherapeutics;2017

3. Simultaneous Determination of a Fixed-Dose Combination of Lercanidipine and Valsartan in Human Plasma by LC–MS-MS: Application to a Pharmacokinetic Study;Journal of Chromatographic Science;2016-07-12

4. Pleiotropic features of dihydropyridine calcium channel antagonists;Systemic Hypertension;2014-09-15

5. Efficacy and safety of the treatment: combination of benazepril/lercanidipine vs. benazepril alone in patients with mild-to-moderate hypertension;Chinese Medical Journal;2013-06-20